文献速递中药与中成药合理使用

靛玉红单次口服在小鼠体内的药代动力学与组织分布研究

Study on pharmacokinetics and tissue distribution of single dose oral tryptanthrin in Kunming mice by validated reversed-phase high-performance liquid chromatography with ultraviolet detection.
PubMed 文献 · Integr Med Res · 2017-05-25

本研究建立并验证了反相高效液相色谱-紫外检测法(RP-HPLC-UV),首次考察昆明小鼠单次口服80 mg/kg靛玉红后的药代动力学与组织分布。结果显示靛玉红在2.5小时内达峰,血浆Cmax为3.13 μg/mL、AUC0-t为9.38 h·μg/mL、终末半衰期2.27小时,组织中以肝脏Cmax最高(均值3.54 μg/g),其次为肾、肺、脾、心、脑。

要点

  • 小鼠口服靛玉红后2.5小时内血浆与各组织达峰,组织分布以肝最高,其次肾、肺。
  • 血浆Cmax 3.13 μg/mL、AUC0-t 9.38 h·μg/mL、终末半衰期2.27小时。
  • 靛玉红与血浆、肝、肾、肺关系密切,其临床研究宜关注这些组织的药效与安全性。

核心结论

  • 研究确认靛玉红口服后与血浆、肝脏、肾脏和肺密切相关并靶向分布,提示其在肝、肾或肺疾病中有较好临床应用前景。

研究设计与样本

  • 研究为昆明小鼠单次口服80 mg/kg靛玉红的药代动力学与组织分布研究,首次开展该体内处置过程考察。
  • 采集小鼠血浆、肝、心、脾、肺、肾和脑,经简单液液萃取后以验证过的RP-HPLC-UV法分析。

主要发现

  • 小鼠血浆与各组织最高浓度均在2.5小时内达到。
  • 血浆实际Cmax为3.13 μg/mL,AUC0-t为9.38 h·μg/mL,终末半衰期为2.27小时。
  • 表观分布容积343.89 mL,清除率204.58 mL/h,口服后药代动力学符合二室一级模型。
  • 组织Cmax以肝脏最高(均值3.54 μg/g),其后依次为肾、肺、脾、心、脑。

关键数值与推荐

  • 色谱柱为Diamonsil C18柱(5 μm,250 mm×4.6 mm),紫外检测波长251 nm。
  • 流动相为甲醇(A)与水(B)(60:40,v/v),流速1.0 mL/min。
  • 方法在4.0–400.0 μg/mL范围内线性良好,定量下限为0.10–0.30 μg/mL。
  • 日内与日间精密度(相对标准偏差%)均在2.93%以内,回收率均高于86.44%。

临床怎么用

  • 靛玉红口服后肝、肾、肺组织暴露较高,临床探索可优先关注这些组织相关适应证。
  • 后续临床使用应重点开展上述组织的药效学与安全性研究,并注意其半衰期较短的特点。

局限性

  • 研究仅于昆明小鼠单次口服80 mg/kg后进行,未涉及重复给药、人体数据或其他种属。
  • 原文未报告组织分布的其他定量参数与安全性指标,外推到临床需谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Tryptanthrin is a major active constituent of several Chinese herbal plants, such as Isatidis radix. Tryptanthrin had been demonstrated to have several beneficial pharmacological effects in vitro for human diseases, including antitumor, anti-inflammatory and antibacteria activities. In contrast to the extensive in vitro investigations, the in vivo disposition process of tryptanthrin was explored limitedly. METHODS: In this study, the pharmacokinetics (PK) and tissue distribution of tryptanthrin in Kunming mice following a single oral dose of 80 mg/kg tryptanthrin were investigated for the first time. Mouse plasma, liver, heart, spleen, lung, kidney and brain were collected and analyzed using a validated reversed-phase high-performance liquid chromatography with ultraviolet detection (RP-HPLC-UV) method after biological sample preparation by a simple liquid-liquid extraction. RESULTS: The chromatographic analysis was performed on a Diamonsil C18 column (5 μm, 250 mm × 4.6 mm) and ultraviolet detection was set at a wavelength of 251 nm. The analysis was achieved with a mobile phase of methanol (A) and water (B) (60:40, v/v) at a flow rate of 1.0 mL/min. The method was linear over the concentration range of 4.0-400.0 μg/mL with a lower limit of quantification of 0.10-0.30 μg/mL. Inter- and intraday precisions (relative standard deviations %) were all within 2.93%. Recoveries of tryptanthrin were more than 86.44%. Maximal tryptanthrin concentrations in plasma and tissues of mice were reached within 2.5 hours. The actual highest concentration (Cmax) in mouse plasma was 3.13 μg/mL, the area under the curve (AUC0-t ) was 9.38 h μg/mL, and the terminal half-life was 2.27 hours. The volume of distribution was 343.89 mL, the clearance rate was 204.58 mL/h, and the PK of tryptanthrin in mice after oral administration was fit to 2 compartment 1 st Order. After oral dosing of tryptanthrin to Kunming mice, the analyte was well distributed to the plasma and main tissues. Cmax was found in the liver with a mean value of 3.54 μg/g, followed by that in the kidney, lung, spleen, heart, and brain. CONCLUSION: In this study, a validated RP-HPLC-UV method was developed and successfully applied to PK and tissue distribution of oral tryptanthrin in mice. We confirmed that tryptanthrin was closely related and targeted to plasma, liver, kidney, and lung. These results indicate that tryptanthrin will have a good clinical application in the liver, kidney, or lung. The clinical use of tryptanthrin should focus on its pharmacodynamics and safety study in these tissues.

来源:Integr Med Res,查看原文。版权归原作者所有。

引用

  1. Zhang X, Xia J, Zhang W, et al. Study on pharmacokinetics and tissue distribution of single dose oral tryptanthrin in Kunming mice by validated reversed-phase high-performance liquid chromatography with ultraviolet detection. Integr Med Res. 2017. PMID: 28951841. doi:10.1016/j.imr.2017.05.001

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。